You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Title |
Pharmacokinetics, SAfety/tolerability, and EFficacy of high-dose RIFampicin in tuberculosis-HIV co-infected patients on efavirenz- or dolutegravir-based antiretroviral therapy: study protocol for an open-label, phase II clinical trial (SAEFRIF)
|
---|---|
Published in |
Trials, February 2020
|
DOI | 10.1186/s13063-020-4132-7 |
Pubmed ID | |
Authors |
Ruth Nabisere, Joseph Musaazi, Paolo Denti, Florence Aber, Mohammed Lamorde, Kelly E. Dooley, Rob Aarnoutse, Derek J. Sloan, Christine Sekaggya-Wiltshire |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 3 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 67% |
Scientists | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 94 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 94 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 10 | 11% |
Unspecified | 9 | 10% |
Student > Master | 9 | 10% |
Student > Ph. D. Student | 8 | 9% |
Student > Bachelor | 5 | 5% |
Other | 20 | 21% |
Unknown | 33 | 35% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 25 | 27% |
Unspecified | 9 | 10% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 6% |
Nursing and Health Professions | 5 | 5% |
Immunology and Microbiology | 2 | 2% |
Other | 12 | 13% |
Unknown | 35 | 37% |